Alkyl Amines Chemicals Ltd (ALKYLAMINE)
๐ฏ Key Takeaways
- Alkyl Amines Chemicals Ltd is in a stable growth phase, characterized by consistent revenue expansion and strong profitability metrics, supported by leadership continuity and conservative capital structure. Management has institutionalized executive succession through formal re-designations and profit-linked incentives, signaling long-term governance discipline.
- Revenue declined 8.6% QoQ to โน235 in Q4FY20.
- โ ๏ธ 1) Overreliance on cyclical chemical demand and commodity price volatility, particularly for acetonitrile and amines, which could pressure margins. 2)
- Market Cap
- โน9,195
- P/E Ratio
- 45.7
- P/B Ratio
- 17.13
- ROE
- 30.7%
- ROCE
- 43.8%
- Debt/Equity
- 0.09
- Div Yield
- 1.11%
- Promoter
- 72.0%
๐ The Story
Alkyl Amines Chemicals Ltd is in a stable growth phase, characterized by consistent revenue expansion and strong profitability metrics, supported by leadership continuity and conservative capital structure. Management has institutionalized executive succession through formal re-designations and profit-linked incentives, signaling long-term governance discipline.
๐ฐ What's Happening
In Q1 FY26, revenue surged to โน537.31 crores from โน395.18 crores in the prior quarter, driven by operational expansion and favorable market conditions. The board approved the re-designation of Yogesh Kothari as Executive Chairman and appointed Kirat Patel and Suneet Kothari as Joint Managing Directors effective October 1, 2026, alongside Rakesh Goyal as Executive Director - Operations for five years starting April 1, 2027. Shareholders endorsed these changes via postal ballot in August 2026, along with approval of non-executive director commissions up to 1% of net profits for five years beginning FY27. These moves reflect a structured succession plan and alignment of director incentives with profitability.
Source: Stock Announcements
๐ Quarterly Results (โน Cr)
| Metric | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 |
|---|---|---|---|---|
| Revenue | 266 | 235 | 257 | 235 |
| Operating Profit | 53 | 51 | 66 | 60 |
| OPM % | 19.8% | 21.8% | 25.6% | 25.7% |
| Net Profit | 37 | 55 | 60 | 49 |
| EPS | โน17.98 | โน26.93 | โน29.62 | โน24.13 |
The company demonstrated robust top-line growth in Q1 FY26, with revenue increasing sequentially from โน395.18 crores to โน537.31 crores, accompanied by a healthy rise in profitability. Despite flat operating margins in earlier quarters, the current trajectory suggests improved operational leverage, supported by scale and possibly favorable raw material dynamics. The consistent EPS growth and high ROE/ROCE indicate strong capital efficiency, though margin pressure in prior quarters warrants monitoring of cost structures amid input price volatility.
๐ฎ Management Outlook & What's Next
Management has not provided explicit forward guidance on revenue or margin expectations in the latest filings. However, the board highlighted plans for capital expenditure, anti-dumping duty approval for acetonitrile, and remuneration ratification as part of ongoing strategic initiatives. The focus remains on sustaining growth through operational excellence and regulatory advantages, with future performance likely tied to execution of expansion plans and commodity cycle dynamics.
Extracted from official company announcements. Not StockFin.ai's opinion.
๐ฆ Balance Sheet (โน Cr)
| Item | Mar 2019 | Mar 2020 | Mar 2020 |
|---|---|---|---|
| Equity Capital | 10 | 10 | 10 |
| Reserves | 369 | 526 | 442 |
| Borrowings | 130 | 48 | 86 |
| Total Liabilities | 763 | 783 | 766 |
| Fixed Assets | 376 | 423 | 383 |
| Investments | 16 | 0 | 18 |
| Total Assets | 763 | 783 | 766 |
The balance sheet remains exceptionally strong, with negligible debt (D/E of 0.09) and growing equity and reserves, reflecting a conservative capital structure. Total assets have risen steadily, indicating reinvestment of earnings rather than aggressive leverage. This financial prudence supports long-term resilience and flexibility for strategic investments or downturns, though the lack of debt capacity may limit large-scale acquisitions.
๐ฐ Cash Flow Statement (โน Cr)
| Item | Mar 2020 |
|---|---|
| Operating | +188 |
| Investing | -41 |
| Financing | -135 |
| Net Cash Flow | +12 |
๐ฅ Shareholding Pattern
| Category | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|
| Promoters | 72.0% | 72.0% | 72.0% | 72.0% |
| FII | 3.4% | 3.5% | 3.5% | 3.5% |
| DII | 2.9% | 3.0% | 3.0% | 3.1% |
| Public | 17.5% | 17.3% | 17.3% | 17.2% |
| # Shareholders | 1,53,451 | 1,49,324 | 1,46,028 | 1,42,625 |
Promoter holding remains stable near 72%, with slight fluctuations in institutional interest. FII ownership has modestly increased from 3.43% to 3.49% over recent quarters, while DII rose from 2.89% to 3.1%, suggesting growing confidence among foreign and domestic institutional investors. The expanding shareholder base (1,42,625 individuals) reflects retail participation, but no significant accumulation or exit signals are evident from the data.
โ๏ธ Peer Comparison โ Chemicals
| Company | MCap (โน Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| PIDILITIND | 1.53 L Cr | 57.6 | 33.4% | โ | 0.01 |
| SRF | 73,810 | 34.1 | 15.6% | โ | 0.36 |
| LINDEINDIA | 52,814 | 96.7 | 17.5% | โ | 0.00 |
| FLUOROCHEM | 48,774 | 79.7 | 9.6% | โ | 0.34 |
| NAVINFLUOR | 43,256 | 54.7 | 22.2% | โ | 0.31 |
| GODREJIND | 36,153 | 30.8 | 9.2% | โ | 4.57 |
| HSCL | 33,807 | 42.0 | 20.7% | โ | 0.16 |
| AETHER | 23,029 | 97.7 | 13.8% | โ | 0.08 |
| DEEPAKNTR | 21,155 | 27.0 | 15.3% | โ | 0.26 |
| CASTROLIND | 19,891 | 18.7 | 76.2% | โ | 0.00 |
๐ Peer Stock Analyses
โ ๏ธ Risk Factors
1) Overreliance on cyclical chemical demand and commodity price volatility, particularly for acetonitrile and amines, which could pressure margins. 2) Regulatory exposure, as seen with anti-dumping duty approvals, which may face legal or geopolitical challenges. 3) Leadership transition risks despite re-designations, given the long-term nature of roles but potential execution gaps in new responsibilities. 4) Limited debt capacity may constrain growth financing in capital-intensive expansion phases.
๐ Recent Filings
- Announcement2026-09-24Alkyl Amines Chemicals Ltd announced that its trading window will close on October 1, 2026, to facilitate disclosure of unaudited quarterly results enโฆ
- ๐ด Corporate Action2026-09-17Alkyl Amines Chemicals approved the allotment of 2,047 equity shares to eligible employees under its ESOP-2018 plan on September 17, 2026, increasing โฆ
- ๐ก voting results2026-08-18Alkyl Amines Chemicals Limited announced shareholder approval via postal ballot for key managerial appointments and compensation changes. Shareholdersโฆ
- ๐ก Board Meeting2026-08-04The board approved unaudited Q1 FY26 results showing revenue of **โน537.31 crores**, up from **โน395.18 crores** in Q4 FY26, and re-designated Yogesh Koโฆ
- ๐ก Board Meeting2026-08-04Alkyl Amines Chemicals announced board approval of unaudited Q1 FY26 results showing revenue of **โน537.31 crores**, profit after tax of **โน94.63 croreโฆ
- ๐ก Board Meeting2026-07-03Alkyl Amines Chemicals held its 46th AGM on July 3, 2026 via video conference, with Chairman Yogesh Kothari presiding. Shareholders approved the auditโฆ
- ๐ก Board Meeting2026-06-16The Board approved a circular resolution on June 16, 2026 to allot 2,125 equity shares of Rs. 2 each to eligible employees under the 2018 ESOP scheme,โฆ
- ๐ด annual report2026-06-09Alkyl Amines Chemicals Limited reported FY 2025-26 revenue of โน1,51,188.46 lakhs, profit after tax of โน17,999.91 lakhs, and declared a โน10 per share dโฆ
- ๐ด annual report2026-06-09Alkyl Amines Chemicals Limited announced that it is dispatching the Annual Report for FY 2025-26 to shareholders whose email addresses are not registeโฆ
- ๐ด Announcement2026-06-05No summary available
๐ง Analyst's Read
Alkyl Amines Chemicals exhibits strong fundamentals and governance discipline, with growth underpinned by operational scale and favorable positioning in specialty chemicals. Investors should monitor execution of expansion plans, input cost trends, and any shifts in institutional sentiment, as the company navigates a maturing lifecycle with disciplined capital allocation.
Based on filing content and financial data. Not a recommendation.
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights โ sign up free to unlock.
Sign Up Free โ Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only โ not investment advice. Updated 2026-09-29.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
๐ก Get AI alerts when ALKYLAMINE files new disclosures
Track ALKYLAMINE filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track ALKYLAMINE โ FreeFree account ยท 2 AI queries/day